Hypothyroidism Treatment with Levothyroxine and Liothyronine

Monitoring and Safety Considerations

Regular monitoring of thyroid function tests (TSH, free T4, free T3) every 4-6 weeks after each dose adjustment is crucial, and target a normal TSH within the reference range unless specific indications for TSH suppression exist, according to Praxis Medical Insights 1
Patients with cardiac disease require more careful monitoring due to potential cardiovascular effects of T3, and avoid rapid dose escalation, particularly in elderly patients or those with cardiovascular disease, as recommended by Praxis Medical Insights 1
Monitor for signs of hyperthyroidism: palpitations, anxiety, insomnia, weight loss, and heat intolerance, as advised by Praxis Medical Insights 1

Pregnant women or those planning pregnancy who have subclinical hypothyroidism should be treated with levothyroxine monotherapy to restore TSH to the reference range, as recommended by the American Medical Association 2
Levothyroxine requirements often increase during pregnancy, necessitating TSH monitoring every 6-8 weeks, according to the American Medical Association 2

Overtreatment with thyroid hormones can increase risk for osteoporosis, fractures, abnormal cardiac output, or ventricular hypertrophy, as reported by the American College of Physicians 3